Vor Ort
Merkzettel Warenkorb
Produktbild: Next Generation Sequencing in Cancer Research, Volume 2
- 10%

Next Generation Sequencing in Cancer Research, Volume 2 From Basepairs to Bedsides

10% sparen

172,99 € UVP 192,59 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

06.05.2015

Abbildungen

XVIII, 493 p. 78 illus., 70 illus. in color.

Herausgeber

Wei Wu + weitere

Verlag

Springer

Seitenzahl

493

Maße (L/B/H)

24,1/16/3,3 cm

Gewicht

928 g

Auflage

2015

Sprache

Englisch

ISBN

978-3-319-15810-5

Beschreibung

Portrait

Wei Wu, M.D., Ph.D. is a Research Associate for the Department of Bio Science at the University of Calgary, specializing in the cancer genome and systems biology. He has edited two volumes with Springer. In addition, he's a member of various editorial board for journals including the International Journal of Biomedical Sciences, International Journal of Molecular Medicine and Advances in Sciences and the Research Journal of Biological Sciences. Hani Choudhry, D.Phil is a member of the Genomics Research Group at the Wellcome Trust Centre for Human Genetics at Oxford University. His expertise is in high throughput next generation sequencing.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

06.05.2015

Abbildungen

XVIII, 493 p. 78 illus., 70 illus. in color.

Herausgeber

Verlag

Springer

Seitenzahl

493

Maße (L/B/H)

24,1/16/3,3 cm

Gewicht

928 g

Auflage

2015

Sprache

Englisch

ISBN

978-3-319-15810-5

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
Die Leseprobe wird geladen.
  • Produktbild: Next Generation Sequencing in Cancer Research, Volume 2

  • Single-cell next Generation Sequencing and Its Applications in Cancer Biology.- Utility of Next Generation Sequencing in Cancer Drug Development and Clinical Trials.- Next-Generation Sequencing in the Era of Cancer-Targeted Therapies: Towards the Personalised Medicine.
    -
    Mutational Similarities Across Cancers: Implications for Research, Diagnostics and Personalized Therapy Design.- Standardized Decision Support in NGS Reports of Somatic Cancer Variants.- Clinical Considerations in the Conduct of Cancer Next Generation Sequencing Testing and Genetic Counselling.- Next Generation Sequencing for Cancer Biomarker Discovery.- Validation and Implementation of Next Generation Sequencing Technologies in a Clinical Molecular Diagnostic Laboratory.- Next Generation Sequencing Technologies and Formalin Fixed Paraffin Embedded Tissue: Application to Clinical Cancer Research.- Applications of NGS to Screen FFPE Tumours for Detecting Fusion Transcripts.- Clinical Application of Next-Generation Sequencing of Formalin-Fixed Paraffin-Embedded Tumors.- ChIP-BS-Sequencing in Cancer Epigenomics.- Integrative Analysis Identifies Transcription Factor-DNA Methylation Relationships and Introduces New Avenues for Translating Cancer Epigenetics Into the Clinic.- Differential Methylation Analysis with Next-Generation Sequencing.- Performance Comparison and Data Analysis Strategies for MicroRNA Profiling in Cancer Research.- Small RNA Sequencing for Squamous Cell Carcinoma Research.- Exome Capture and Capturing Technologies in Cancer Research.-

    The Landscape of DNA Virus Associations Across Human Malignant Cancers.- Using Next Generation Sequencing to Reveal Patterns of Chromosomal Alterations in Oral Verrucous Carcinoma.- Vironomics: The Study of Viral Genomics in Human Cancer and Disease.-

    Molecular Typing of Lung Adenocarcinoma on Cytological Samples in the Next Generation Sequencing Era.- Whole Genome/Exome Sequencing in Acute Leukemia: From Research to Clinics.- Next Generation Sequencing Applications in Head and Neck Oncology.- CIC Mutation in Brain Tumor
    .-
    Isocitrate Dehydrogenase (IDH) Mutation in Gliomas.-

    Utilization of Multigene Panels in Hereditary Cancer Predisposition Testing.